We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$175M
AUM Growth
+$752K
Cap. Flow
-$4.94M
Cap. Flow %
-2.83%
Top 10 Hldgs %
38.79%
Holding
105
New
5
Increased
4
Reduced
58
Closed
3

Top Sells

Rank Stock Value
1
CBRE icon
CBRE Group
CBRE
+$2.24M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.22M
3
BAX icon
Baxter International
BAX
+$494K
4
DOUG icon
Douglas Elliman
DOUG
+$467K
5
BCE icon
BCE
BCE
+$350K

Sector Composition

Rank Sector Weight
1 Technology 20.82%
2 Healthcare 18.81%
3 Industrials 17.94%
4 Financials 14.63%
5 Consumer Staples 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
26
Lockheed Martin
LMT
$134B
$2.37M 1.36%
5,015
-30
-0.6% -$14.1K
AMGN icon
27
Amgen
AMGN
$203B
$2.33M 1.33%
9,631
-90
-0.9% -$22.1K
ETN icon
28
Eaton
ETN
$157B
$2.22M 1.27%
12,982
-1,920
-13% -$320K
MRNA icon
29
Moderna
MRNA
$21.5B
$2.21M 1.26%
14,367
-277
-2% -$45.7K
MSFT icon
30
Microsoft
MSFT
$2.84T
$2.11M 1.21%
7,323
+5
+0.1% +$1.27K
V icon
31
Visa
V
$677B
$2.11M 1.21%
9,353
-149
-2% -$33.2K
MLM icon
32
Martin Marietta Materials
MLM
$33.6B
$1.8M 1.03%
5,075
-680
-12% -$239K
BAM icon
33
Brookfield Asset Management
BAM
$74B
$1.7M 0.97%
51,940
+17,898
+53% +$581K
TRP icon
34
TC Energy
TRP
$73.5B
$1.7M 0.97%
43,587
-3,738
-8% -$152K
SYF icon
35
Synchrony
SYF
$23.7B
$1.69M 0.97%
58,117
-1,810
-3% -$60.8K
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$121B
$1.6M 0.92%
5,085
-100
-2% -$30K
CI icon
37
Cigna
CI
$76.6B
$1.56M 0.89%
6,108
-175
-3% -$51K
J icon
38
Jacobs Solutions
J
$15.9B
$1.55M 0.89%
15,915
-278
-2% -$27.7K
HSY icon
39
Hershey
HSY
$35.4B
$1.45M 0.83%
5,685
-240
-4% -$56.4K
QCOM icon
40
Qualcomm
QCOM
$176B
$1.27M 0.73%
9,920
+390
+4% +$48.5K
MRK icon
41
Merck
MRK
$324B
$1.26M 0.72%
11,821
-150
-1% -$16.2K
COO icon
42
Cooper Companies
COO
$13.7B
$1.25M 0.72%
13,420
-260
-2% -$22.4K
STZ icon
43
Constellation Brands
STZ
$22.2B
$1.24M 0.71%
5,506
-200
-4% -$44.5K
CVS icon
44
CVS Health
CVS
$137B
$1.14M 0.65%
15,274
-249
-2% -$20.9K
AMZN icon
45
Amazon
AMZN
$2.5T
$1.12M 0.64%
10,800
-100
-0.9% -$9.66K
JNJ icon
46
Johnson & Johnson
JNJ
$635B
$1.11M 0.63%
7,150
+1
+0% +$161
DENN
47
DELISTED
Denny's
DENN
$1.02M 0.58%
91,136
-2,320
-2% -$27K
PRU icon
48
Prudential Financial
PRU
$41.7B
$1M 0.57%
12,095
-298
-2% -$28.4K
MDT icon
49
Medtronic
MDT
$107B
$970K 0.56%
12,032
-324
-3% -$26.4K
GEHC icon
50
GE HealthCare
GEHC
$27.6B
$968K 0.55%
+11,805
New +$843K

Similar funds

Lipe & Dalton's Q1 2023 Portfolio in Review

As of Q1 2023, Lipe & Dalton held 105 positions worth $175M, up 0.43% from $174M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Lipe & Dalton's Q1 2023 filing shows 5 new, 4 increased, 58 reduced and 3 closed positions. Its largest new stake was Ball Corp: 50,013 shares worth $2.76M. The largest sale was CBRE Group, an estimated $2.24M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Lipe & Dalton's largest Q1 2023 buy was Ball Corp: 50,013 shares worth $2.76M.
  • Lipe & Dalton added most to Brookfield Asset Management in Q1 2023, an estimated $581K increase.
  • Lipe & Dalton's biggest Q1 2023 reduction was Bristol-Myers Squibb, cutting an estimated $1.22M.
  • Lipe & Dalton fully exited CBRE Group in Q1 2023, selling an estimated $2.24M.
  • Lipe & Dalton's ten largest holdings make up 39% of its $175M portfolio in Q1 2023.
  • Lipe & Dalton opened 5 new positions and closed 3 in Q1 2023.
  • Lipe & Dalton's portfolio value rose 0.43% quarter-over-quarter to $175M.

Based on Lipe & Dalton's 13F filing for Q1 2023, filed 2 May 2023.